| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/1995 | WO1995000520A1 Indolocarbazole compound useful as proteinkinase c inhibitor |
| 01/05/1995 | WO1995000517A1 Process for producing imidazole derivative |
| 01/05/1995 | WO1995000516A1 Novel chemical compounds having pde-iv inhibition activity |
| 01/05/1995 | WO1995000515A1 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 01/05/1995 | WO1995000514A1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/05/1995 | WO1995000512A1 Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 01/05/1995 | WO1995000511A1 Condensed 4-aminopyridines with antirheumatic activity |
| 01/05/1995 | WO1995000510A1 Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one |
| 01/05/1995 | WO1995000508A1 Phenyrrole derivatives and their use as dopamine d3 antagonists |
| 01/05/1995 | WO1995000507A1 Azolyl-cyclic amine derivatives with immunomodulatory activity |
| 01/05/1995 | WO1995000505A1 Aminoacid derivatives as no synthase inhibitors |
| 01/05/1995 | WO1995000501A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | WO1995000497A1 Inhibitors of farnesyl-protein transferase |
| 01/05/1995 | WO1995000494A1 Novel method for preparing ergothioneine |
| 01/05/1995 | WO1995000493A1 Imidazole derivatives as therapeutic agents |
| 01/05/1995 | WO1995000490A1 Bis-imide polycyclic and heterocyclic chromophores useful as tumoricidals |
| 01/05/1995 | WO1995000489A1 Isoquinoline derivatives as therapeutic agents |
| 01/05/1995 | WO1995000486A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | WO1995000485A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | WO1995000484A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | WO1995000483A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | WO1995000482A1 Piperidine derivatives and process for their production |
| 01/05/1995 | WO1995000480A1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 01/05/1995 | WO1995000477A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 01/05/1995 | WO1995000472A1 1,2 diacylated hydrazine derivatives and their use as all adhesion inhibitors |
| 01/05/1995 | WO1995000471A1 Benzene derivative useful for ischemic diseases |
| 01/05/1995 | WO1995000176A1 Compositions for treating hypoxia-associated ocular complications |
| 01/05/1995 | WO1995000175A1 Agent with influences hyperactive immunological effector cells |
| 01/05/1995 | WO1995000158A1 Dietary supplement incorporating beta-sitosterol and pectin |
| 01/05/1995 | WO1995000157A1 Therapeutic agent |
| 01/05/1995 | WO1995000154A1 Antidepressant agents with a rapid onset of action |
| 01/05/1995 | WO1995000153A1 Methods for inhibiting skin ulceration by use of cyanoacrylate adhesives |
| 01/05/1995 | WO1995000152A1 Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters |
| 01/05/1995 | WO1995000150A1 Blood vessel thickening inhibitor and smooth muscle fiber migration inhibitor each containing 7-thiaprostaglandin e1 compound as active ingredient |
| 01/05/1995 | WO1995000149A1 Dopamine reincorporation inhibitor |
| 01/05/1995 | WO1995000148A1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 01/05/1995 | WO1995000147A1 4-AZA-PREGNANE 5α-REDUCTASE ISOZYME 1 INHIBITORS |
| 01/05/1995 | WO1995000145A1 Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease |
| 01/05/1995 | WO1995000144A1 Composition for ophthalmic use |
| 01/05/1995 | WO1995000143A1 Composition for ophthalmic use |
| 01/05/1995 | WO1995000142A1 NEW PHARMACEUTICAL PREPARATIONS, CONTAINING 8-CHLORO-3(betaDIETHYLAMINOETHYL)-4-METHYL-7-ETHOXYCARBONYLMETHOXY COUMARIN AND THE SALTS THEREOF, IN THE TREATMENT OF PATHOLOGICAL CONDITIONS INVOLVING HIGH RELEASE OF NITRIC OXIDE |
| 01/05/1995 | WO1995000141A1 Compounds for the photodecontamination of pathogens in blood |
| 01/05/1995 | WO1995000139A1 Compounds |
| 01/05/1995 | WO1995000138A1 Use of acylcarnitides for treating aids |
| 01/05/1995 | WO1995000137A1 Use of acylcarnitin to treat illnesses caused by aids |
| 01/05/1995 | WO1995000136A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | WO1995000135A1 Medical treatment using thyroid hormones |
| 01/05/1995 | WO1995000134A1 Liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl)propionic acid |
| 01/05/1995 | WO1995000133A1 Taste-masked acetaminophen suspensions and methods of making the same |
| 01/05/1995 | WO1995000132A1 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin |
| 01/05/1995 | WO1995000130A1 Use of hydrophilic carotenoids for the manufacture of a medicament for the treatment of diseases having an oxygenation mechanism |
| 01/05/1995 | WO1995000129A1 Treatment of multidrug resistant diseases |
| 01/05/1995 | WO1995000112A1 Photoprotection compositions comprising certain chelating agents |
| 01/05/1995 | WO1995000042A2 Food and/or pharmaceutical composition having a low polyamine content |
| 01/05/1995 | WO1995000041A1 Food and/or pharmaceutical composition having a low polyamine content, and therapeutical uses thereof |
| 01/05/1995 | WO1995000018A1 Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption |
| 01/05/1995 | WO1994026263A3 Use of a transition metal complex for the treatment of septic shock |
| 01/05/1995 | WO1994022445A3 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
| 01/05/1995 | DE4320898A1 Product for the therapy and prophylaxis of disorders occurring in cases of plasma lipid imbalance |
| 01/05/1995 | DE4320896A1 Product for the therapy and prophylaxis of dementias |
| 01/05/1995 | DE4320822A1 Pharmaceutical composition with a novel type of action |
| 01/05/1995 | DE4320802A1 2-Hydroxyphenyl-substituted imidazoles, their use as pharmaceutical agents and pharmaceutical compositions containing them |
| 01/05/1995 | DE4320801A1 2-Hydroxyphenyl-substituted 1,2,4-triazoles and 1,2,4-oxadiazoles, their use as pharmaceutical agents and pharmaceutical compositions containing them |
| 01/05/1995 | DE4320694A1 Wart remedy for external use |
| 01/05/1995 | CA2364039A1 Use of phenyl heterocycles in the relief or treatment of rheumatoid arthritis, osteoarthritis, fever, pain, headache or dysmenorrhea |
| 01/05/1995 | CA2166813A1 New phosphonosuccinic acid derivatives, processes for the production thereof and pharmaceutical agents containing these compounds |
| 01/05/1995 | CA2165950A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | CA2165948A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | CA2165947A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | CA2165946A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | CA2165823A1 Isoquinoline derivatives as therapeutic agents |
| 01/05/1995 | CA2165822A1 The medical treatment using thyroid hormones |
| 01/05/1995 | CA2165794A1 Therapeutic agent |
| 01/05/1995 | CA2165782A1 Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption |
| 01/05/1995 | CA2165765A1 Bis-imide polycyclic and heterocyclic chromophores useful as tumoricidals |
| 01/05/1995 | CA2165662A1 Benzene derivatives effective on ischemic diseases |
| 01/05/1995 | CA2165481A1 Food and/or pharmaceutical composition having a low polyamine content, and therapeutical uses thereof |
| 01/05/1995 | CA2165454A1 Food and/or pharmaceutical composition having a low polyamine content |
| 01/05/1995 | CA2165437A1 Utilization of efaroxan and derivatives therof for the preparation of a medicament intended to the treatment of parkinson disease |
| 01/05/1995 | CA2165176A1 Inhibitors of farnesyl-protein transferase |
| 01/05/1995 | CA2165077A1 4-aza-pregnane 5.alpha.-reductase isozyme 1 inhibitors |
| 01/05/1995 | CA2164966A1 Compositions and methods for anti-addictive narcotic analgesis activity screening and treatments |
| 01/05/1995 | CA2164961A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 01/05/1995 | CA2164955A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | CA2164865A1 Suppressant for vascular hypertrophy and suppressant for wandering smooth muscle cells containing 7-thiaprostaglandin e1 compound as active ingredient |
| 01/05/1995 | CA2164424A1 Mesothelial cell gene therapy |
| 01/05/1995 | CA2163986A1 Dopamine re-uptake inhibitor |
| 01/05/1995 | CA2163888A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | CA2161436A1 Antiproliferative naphthyridines |
| 01/05/1995 | CA2142725A1 Use of acylcarnitides for treating aids |
| 01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 01/04/1995 | EP0632051A1 Anti-picornaviral agents |
| 01/04/1995 | EP0632042A1 Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6 |
| 01/04/1995 | EP0632040A1 Antibacterial imidazole derivatives |
| 01/04/1995 | EP0632039A1 2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives |
| 01/04/1995 | EP0632036A2 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 01/04/1995 | EP0632035A1 Aminoalkylchomones, process for their preparation and pharmaceutical compositions containing them |
| 01/04/1995 | EP0632033A1 Novel benzopyran derivative |
| 01/04/1995 | EP0632026A1 Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them |
| 01/04/1995 | EP0632020A1 Allophanic acid derivatives |